SCHEMBL16620549

SCHEMBL16620549

Nc1cc(I)c2cc[nH]c2n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 2/20 0.44
ADORA2A P29274 3/20 0.37
ADORA1 P30542 3/20 0.37
HRH4 Q9H3N8 2/20 0.37
CSNK1D P48730 1/20 0.37
IKBKB O14920 1/20 0.36
CHUK O15111 1/20 0.36
TTBK1 Q5TCY1 2/20 0.33
TTBK2 Q6IQ55 2/20 0.33
JAK2 O60674 1/20 0.33
PRKCI P41743 2/20 0.32
AXL P30530 1/20 0.32
NUDT1 P36639 1/20 0.32
MAPK13 O15264 1/20 0.31
MAPK12 P53778 1/20 0.31
MAPK11 Q15759 1/20 0.31
MAPK14 Q16539 1/20 0.31
JAK3 P52333 2/20 0.31
CDC7 O00311 1/20 0.31
DAPK3 O43293 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22232997 0.80 DYRK1A (0.47) DYRK1AADORA2AADORA1HRH4CSNK1D
SCHEMBL4583281 0.77 PRKCI (0.48) DYRK1AADORA2AADORA1HRH4CSNK1D
SCHEMBL30825493 0.77 PRKCI (0.48) DYRK1AADORA2AADORA1HRH4CSNK1D
SCHEMBL30355994 0.77 AXL (0.48) DYRK1AADORA2AADORA1HRH4CSNK1D
SCHEMBL5429185 0.77 AXL (0.48) DYRK1AADORA2AADORA1HRH4CSNK1D
SCHEMBL18012907 0.77 BACE1 (0.47) DYRK1AADORA2AADORA1HRH4CSNK1D
SCHEMBL24809820 0.77 DYRK1A (0.37) DYRK1AADORA2AADORA1JAK2PRKCI
SCHEMBL28732382 0.77 DYRK1A (0.37) DYRK1AADORA2AADORA1HRH4IKBKB
SCHEMBL29452466 0.77 DYRK1A (0.37) DYRK1AADORA2AADORA1HRH4IKBKB
SCHEMBL16620999 0.77 ADORA2A (0.49) DYRK1AADORA2AADORA1JAK2PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3052501-B1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY SCIENCE TECH & RES (SG) 2022-06-22 EP disclosed
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2020-01-28 US disclosed
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-07-12 US disclosed
US-9884867-B2 Bicyclic alkyne derivatives and uses thereof AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2018-02-06 US disclosed
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2016-08-11 US disclosed
EP-3052501-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF Agency For Science, Technology And Research (SG) 2016-08-10 EP disclosed
WO-2015050505-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) 2015-04-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160229860-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF MAPKAPK2, CAMKK2, MKNK2 DYRK1A 472/4885ADORA2A 740/4885ADORA1 2070/4885
US-10544149-B2 Bicyclic alkyne derivatives and uses thereof MAPKAPK2, MAP4K2, MKNK2 DYRK1A 436/4885ADORA2A 716/4885ADORA1 1952/4885
US-20180194771-A1 BICYCLIC ALKYNE DERIVATIVES AND USES THEREOF MAPKAPK2, CAMKK2, MKNK2 DYRK1A 472/4885ADORA2A 740/4885ADORA1 2070/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.